Pasternack, A.(Amos Pasternack)
patient protein c-reactive serum treatment streptokinase grade value artery serum c-reactive protein infarct alteplase infarction group study infarct-related thrombolytic treatment thrombolytic infarct size simoons ml infarct-related artery patency reaction combination concentration harmoinen heart enzyme t test dehydrogenase 2 flow thrombolytic therapy angiographic grade 0 gusto-i substudy difference tissue plasminogen activator c-reactive protein manuscript angiography reperfusion simoon analysis 96 hours blood activator thrombolysi enzyme substudy sample hermens wt pietill 1 flow phase reaction werf f hospital multivariate analysis blood samples plasminogen hermen tampere streptokinase treatment release 3 patients alteplase-treated patients verstraete m therapy survival stent survival prognosis randomized trial streptokinase treatment groups phase ttmi grade 0 student tissue tjmi 3 flow mortality research institute maastricht timi classifications .7
1 Most Recent Publications
Comparison of peak serum C-reactive protein and hydroxybutyrate dehydrogenase levels in patients with acute myocardial infarction treated with alteplase and streptokinase
Pietila, K. Hermens, W.T. Harmoinen, A. Baardman, T. Pasternack, A. Topol, E.J. Simoons, M.L.